Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Morgan

Showing results (21-30 of 177) with videos related to

Pageof 18
Sort By:
Alcoholism, Clinical and Experimental Research|November 1, 2022
All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobankJohn B Whitfield, Devanshi Seth, Timothy R Morgan, et al.
Current Treatment Options in Gastroenterology|March 21, 2014
Update on recently approved treatments for hepatitis CDaniel Chao, Gregory J Botwin, Timothy R Morgan
Hepatology (Baltimore, Md.)|June 27, 2002
Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damageKengathevy Morgan, Samuel W French, Timothy R Morgan
Journal of Hepatology|September 2, 2022
Reply to: "External validation of a genetic risk score that predicts development of alcohol-related cirrhosis"John B Whitfield, Timothy R Morgan, Devanshi Seth
Digestive Diseases (Basel, Switzerland)|March 2, 2006
Alcohol and hepatitis CM Mazen Jamal, Zainab Saadi, Timothy R Morgan
Hepatology Communications|January 15, 2025
Reply: Polygenic risk score in cirrhosis: Does the etiology matter?Tae-Hwi Schwantes-An, Timothy R Morgan, Devanshi Seth
European Journal of Gastroenterology & Hepatology|March 25, 2009
Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver diseaseElango Kathirvel, Kengathevy Morgan, Samuel W French, et al.
Nutrition Research (New York, N.Y.)|November 2, 2013
Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver diseaseElango Kathirvel, Kengathevy Morgan, Samuel W French, et al.
Gastroenterology|October 2, 2023
ReplyChristine M Hunt, Tae Hoon Lee, Timothy R Morgan, et al.
The American Journal of Gastroenterology|July 26, 2006
Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosisCharles S Lieber, David G Weiss, Timothy R Morgan, et al.
Pageof 18

Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
Alcoholism, Clinical and Experimental Research|November 1, 2022
All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobankJohn B Whitfield, Devanshi Seth, Timothy R Morgan, et al.
Current Treatment Options in Gastroenterology|March 21, 2014
Update on recently approved treatments for hepatitis CDaniel Chao, Gregory J Botwin, Timothy R Morgan
Hepatology (Baltimore, Md.)|June 27, 2002
Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damageKengathevy Morgan, Samuel W French, Timothy R Morgan
Journal of Hepatology|September 2, 2022
Reply to: "External validation of a genetic risk score that predicts development of alcohol-related cirrhosis"John B Whitfield, Timothy R Morgan, Devanshi Seth
Digestive Diseases (Basel, Switzerland)|March 2, 2006
Alcohol and hepatitis CM Mazen Jamal, Zainab Saadi, Timothy R Morgan
Hepatology Communications|January 15, 2025
Reply: Polygenic risk score in cirrhosis: Does the etiology matter?Tae-Hwi Schwantes-An, Timothy R Morgan, Devanshi Seth
European Journal of Gastroenterology & Hepatology|March 25, 2009
Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver diseaseElango Kathirvel, Kengathevy Morgan, Samuel W French, et al.
Nutrition Research (New York, N.Y.)|November 2, 2013
Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver diseaseElango Kathirvel, Kengathevy Morgan, Samuel W French, et al.
Gastroenterology|October 2, 2023
ReplyChristine M Hunt, Tae Hoon Lee, Timothy R Morgan, et al.
The American Journal of Gastroenterology|July 26, 2006
Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosisCharles S Lieber, David G Weiss, Timothy R Morgan, et al.
Pageof 18